Skip to Content

W 15 (Pioglitazone Hydrochloride 15 mg (base))

Pill with imprint W 15 is White, Round and has been identified as Pioglitazone Hydrochloride 15 mg (base). It is supplied by Watson Laboratories, Inc..

Pioglitazone is used in the treatment of nonalcoholic fatty liver disease; diabetes, type 2 and belongs to the drug class thiazolidinediones. Risk cannot be ruled out during pregnancy. Pioglitazone 15 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for W 15

Pioglitazone hydrochloride 15 mg (base) W 15
Pioglitazone hydrochloride 15 mg (base) W 15
Pioglitazone hydrochloride 15 mg (base) W 15

Pioglitazone Hydrochloride

Imprint:
W 15
Strength:
15 mg (base)
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Thiazolidinediones
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Laboratories, Inc.
Inactive Ingredients:
carboxymethylcellulose calcium
hydroxypropyl cellulose (type l)
lactose monohydrate
magnesium stearate
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
68084-0878 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide